Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 358 (RNA5SP358) is a human genomic locus classified as a rRNA pseudogene, specifically a processed pseudogene of the 5S ribosomal RNA gene[1][7]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; RNA5SP358 is not transcribed into a functional RNA, nor does it encode any protein or ribosomal RNA subunit[1][4][6][7]. Unlike the canonical 5S ribosomal RNA, which is a core structural and functional component of the large ribosomal subunit, and participates in ribosome assembly and translation, pseudogenes such as RNA5SP358 are usually vestigial byproducts of evolutionary events and do not contribute directly to ribosome function or cellular processes[1][7][6][5][3]. Pseudogenes may sometimes play regulatory roles (e.g., sponging microRNAs, impacting gene expression, or rarely yielding regulatory RNA species), but there is no evidence in the current literature that RNA5SP358 has a biological function or established disease role[6][7][1]. Therefore, it is not considered a therapeutic target (e.g., receptor, enzyme, transporter, etc.), and there are no known drugs, mechanisms of action, or safety concerns associated with this locus[1][7]. Essential context: - 5S ribosomal pseudogenes are common in the human genome and typically arise by retrotransposition or duplication events, resulting in nonfunctional copies scattered across the genome[6][4]. - Unlike the parent gene RNA, 5S ribosomal RNA, which forms part of the ribosome and is essential for protein synthesis, pseudogenes like RNA5SP358 do not produce active RNA and do not participate in ribosome function[1][4][5][7]. Summary: RNA5SP358 is a processed rRNA pseudogene with no known function or role as a drug target. It is not considered a disease biomarker or therapy-related target in current biomedical literature[1][7][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 358 (RNA5SP358).